Caveolin-1 in meningiomas: expression and clinico-pathological correlations
V Barresi1, S Cerasoli, G Paioli
1Dipartimento di Patologia Umana, Università degli Studi di Messina, Messina, Italy. valeriabarresi@hotmail.com
Acta Neuropathologica
|July 20, 2006
Summary
Caveolin-1 (Cav-1) expression is increased in most meningiomas and correlates with aggressive tumor features. Higher Cav-1 levels indicate a worse prognosis for patients with these brain tumors.
Area of Science:
- Neuro-oncology
- Molecular pathology
- Cancer research
Background:
- Caveolin-1 (Cav-1) protein's role in neoplasms is debated.
- Understanding Cav-1 in meningiomas is crucial for prognosis.
Purpose of the Study:
- To investigate Cav-1 immunohistochemical expression in human meningiomas.
- To correlate Cav-1 expression with clinicopathological features and patient survival.
Main Methods:
- Analyzed 62 human meningioma cases and 10 normal leptomeningeal samples.
- Utilized immunohistochemistry to assess Cav-1 expression and intensity distribution (ID) score.
- Correlated Cav-1 ID scores with Ki-67 index, tumor grade, and survival data.
Main Results:
- Cav-1 immunoexpression found in 95% of meningiomas, with variable ID scores.
- Higher Cav-1 ID scores correlated significantly with tumor site, Simpson's grade, histological type, higher grade, and Ki-67 index.
- Worse survival observed in patients with higher Cav-1 ID scores and higher Ki-67 levels.
Conclusions:
- Increased Cav-1 immunoexpression is associated with meningioma aggressiveness.
- Cav-1 expression may serve as a prognostic marker for meningiomas.
- While Cav-1 correlates with prognosis, Ki-67 remains the independent prognostic factor.
